Discover how the Eluvia Stent was designed and engineered to solve the unique challenge of restenosis in the SFA. The only SFA stent to utilize polymer-based technology with proven biocompatibility—Eluvia sustains drug release beyond 12 months to match restenosis.
September 9, 2016
WANT TO KNOW MORE?
Join our Drug-Eluting Technologies Community
Sign Up for Product Updates
Receive the latest news of Drug Eluting TechnologiesSIGN UP